+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Asia Pacific Platelet Rich Plasma Market to reach US$110.0 mn by 2023 with Pure PRP Segment in Leading Position

Posted on May 31, 2016

Transparency Market Research has published a new report on the Asia Pacific platelet rich plasma market. As per the report, the Asia Pacific platelet rich plasma market is predicted to expand at a 15.40% CAGR from 2015 to 2023. The report is titled ‘Platelet Rich Plasma Market - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.’ It estimates the Asia Pacific market to progress from US$30.0 mn in 2014 to US$110.0 mn by 2023. Factors such as the rising occurrence of orthopedic disorders and advancements in platelet rich plasma devices are expected to propel the Asia Pacific platelet rich plasma market in the years to come. 

Browse the full Platelet Rich Plasma Market (By Type: Pure PRP, Leucocytes and PRP, Platelet Rich Fibrin; By Origin: Autologous PRP, Allogeneic PRP, and Homologous PRP; By Application: Orthopedic Surgery, Cosmetic Surgery, General Surgery, Neurosurgery, and Other Surgeries) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023 report at https://www.transparencymarketresearch.com/asia-pacific-platelet-rich-plasma-market.html

Platelet rich plasma (PRP) is the donor’s plasma or patient’s own blood plasma used to repair bones and soft tissues or to stimulate regeneration of soft tissues. Platelet rich plasma comprises four to eight platelet concentration as compared to individual blood plasma. Platelets contain hundreds of proteins such as platelet-derived growth factor, platelet-derived epidermal growth factor, transforming growth factor, vascular endothelial growth factor, epidermal growth factor, insulin-like growth factor-1, and others that are essential in healing injuries. The rising prevalence of sports injuries and the increasing application of platelet rich plasma in cosmetic surgeries and plastic surgeries are predicted to propel the Asia Pacific platelet rich plasma market in the near future.

Advancements in PRF and PRP research, the widespread use of PRP, and the growing medical tourism are some of the other factors expected to benefit the Asia Pacific platelet rich plasma market. The Asia Pacific platelet rich plasma market is segmented on the basis of origin, type, country, and application. By type, the Asia Pacific platelet rich plasma market is segmented into platelet rich fibrin, pure PRP, and leucocytes. Currently, the pure PRP segment dominates the Asia Pacific platelet rich plasma market owing to less contamination, low cost, and high concentration of platelets. By origin, the Asia Pacific platelet rich plasma market is divided into autologous PRP, homologous PRP, and allogeneic PRP. At present, the Asia Pacific platelet rich plasma market is dominated by the autologous PRP segment owing to low cost and minimal risk factors.

By country, the Asia Pacific platelet rich plasma market is divided into China, India, Australia, Philippines, Thailand, Singapore, Malaysia, and Taiwan, Hong Kong, and South Korea. Currently, the Asia Pacific platelet rich plasma market is led by China due to increasing investments in PRP research activities.

Some of the leading players operating in the Asia Pacific platelet rich plasma market are Harvest Technology, Stryker Corporation, DePuy Synthes, Cesca Therapeutics, Inc., Rmedica Co. Ltd., Arthrex, Inc., Zimmer Biomet, AdiStem Ltd., and Exactech, Inc. As platelet rich plasma can be used for many new applications, the Asia Pacific platelet rich plasma market is expected to witness new growth opportunities in the years to come. 

Key Segments of Asia Pacific Platelet Rich Plasma Market

Asia Pacific Platelet Rich Plasma Market Revenue, by Type

  • Pure Platelet-Rich Plasma
  • Leukocyte-Rich Platelet-Rich Plasma
  • Pure Platelet-Rich Fibrin / Leukocyte-Rich Platelet-Rich Fibrin

Asia Pacific Platelet Rich Plasma Market Revenue, by Origin

  • Autologous Platelet-Rich Plasma
  • Allogeneic Platelet-Rich Plasma
  • Homologous Platelet-Rich Plasma

Asia Pacific Platelet Rich Plasma Market Revenue, by Application

  • Orthopedic Surgery
  • Cosmetic Surgery
  • General Surgery
  • Neurosurgery
  • Other Surgeries

Asia Pacific Platelet Rich Plasma Market Revenue, by Country

  • Australia
  • Philippines
  • China
  • India
  • Singapore
  • Thailand
  • Malaysia
  • Korea
  • Hong Kong
  • Taiwan
  • Rest of APAC (Indonesia, New Zealand, Vietnam, etc.)

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact

Mr.Sudip S 
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Back To Top